Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option? Fereidan-Esfahani M, Brück W, Weber MS JAMA Neurol. 2015 Oct 12:1-2. PMID: 26458194. Abstract CommentRecommendBookmarkWatch